Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2012 by Policlinique Médicale Universitaire.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Centre Hospitalier Universitaire Vaudois
Swiss HIV Cohort Study
Information provided by (Responsible Party):
Marie Schneider, Policlinique Médicale Universitaire
ClinicalTrials.gov Identifier:
NCT01621347
First received: May 31, 2012
Last updated: June 13, 2012
Last verified: June 2012

May 31, 2012
June 13, 2012
March 2012
August 2012   (final data collection date for primary outcome measure)
Change in patient adherence during pregnancy and postpartum [ Time Frame: before delivery (1 to 9 month) and postpartum (6 month) ] [ Designated as safety issue: No ]
By electronic drug monitoring, pill count and subject interviews' marks
Same as current
Complete list of historical versions of study NCT01621347 on ClinicalTrials.gov Archive Site
Adherence barriers and facilitators [ Time Frame: pregnancy and postpartum (6 months) ] [ Designated as safety issue: No ]
Data recorded in subject's interview marks
Same as current
Not Provided
Not Provided
 
Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women
Retrospective Study: Evaluation of Antiretroviral Adherence During Pregnancy and Postpartum Using Electronic Monitoring Data

The purpose of this study is to compare adherence to antiretroviral therapy during pregnancy and postpartum, and to record adherence barriers and facilitators.

Data of all consecutive pregnant women included in the adherence enhancing program of the Pharmacy, Department of ambulatory care & community medicine, are collected. In this program, adherence is measured and enhanced by electronic monitoring, pill count, motivational interviewing and interdisciplinary collaboration. Electronic monitoring data are collected during pregnancy and postpartum, and compared. Barriers and facilitators are collected using interview's marks.

Observational
Observational Model: Case-Only
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample

Pregnant and Postpartum Women enrolledin the HIV adherence program at the pharmacy of Department of Ambulatory Care and Community Medicine in Lausanne

  • HIV Infection
  • Pregnancy
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
26
September 2012
August 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Pregnant Women
  • HIV-positive
  • Antiretroviral medication delivered in electronical monitors

Exclusion Criteria:

  • Monitored period during pregnancy < 1 month
Female
18 Years and older
No
Contact: Aurélie Gertsch, PhD-Student +41213144846 aurelie.gertsch@hospvd.ch
Contact: Marie-Paule Schneider, PhD +41213144845 Marie-Paule.Schneider@hospvd.ch
Switzerland
 
NCT01621347
48/12
No
Marie Schneider, Policlinique Médicale Universitaire
Policlinique Médicale Universitaire
  • Centre Hospitalier Universitaire Vaudois
  • Swiss HIV Cohort Study
Study Chair: Marie-Paule Schneider, PhD Policlinique Médicale Universitaire
Principal Investigator: Aurélie Gertsch, PhD-Student Policlinique Médicale Universitaire
Study Chair: Olivier Bugnon, Professor Policlinique Médicale Universitaire
Principal Investigator: Odile Michel, Student Policlinique Médicale Universitaire
Study Chair: Matthias Cavassini, M.D Centre Hosppitalier Universitaire Vaudois
Policlinique Médicale Universitaire
June 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP